S Hellsten1, E Rintala, R Wahlqvist, P U Malmström. Show Affiliations » 1. Department of Urology, University Hospital, Malmö, Sweden.
Abstract
Entities: Disease
Mesh： See more » AdultAgedAntineoplastic Combined Chemotherapy Protocols/therapeutic useCarcinoma, Transitional Cell/drug therapyCarcinoma, Transitional Cell/mortalityCarcinoma, Transitional Cell/pathologyCarcinoma, Transitional Cell/secondaryCarcinoma, Transitional Cell/surgeryChemotherapy, AdjuvantCisplatin/administration & dosageCystectomy/methodsDoxorubicin/administration & dosageFemaleFollow-Up StudiesHumansIntestinal Obstruction/surgeryLymphatic MetastasisMaleMiddle AgedMultivariate AnalysisNeoplasm Recurrence, LocalNeoplasm StagingPrognosisProspective StudiesSurvival RateUrethra/surgeryUrinary Bladder Neoplasms/drug therapyUrinary Bladder Neoplasms/mortalityUrinary Bladder Neoplasms/pathologyUrinary Bladder Neoplasms/surgeryUrinary Diversion
Substances： See more » DoxorubicinCisplatin
Year: 1998 PMID： 9615209 DOI： 10.1159/000052263
Source DB: PubMed Journal: Eur Urol ISSN： 0302-2838 Impact factor: 20.096